68
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Cost Analyses of Adjunct Colony Stimulating Factors for Acute Leukemia: Can They Improve Clinical Decision Making

, , , , &
Pages 65-70 | Received 19 Jul 1999, Accepted 29 Jul 1999, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Thomas Lehrnbecher & Ursula Creutzig. (2009) Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma. Expert Review of Hematology 2:2, pages 159-172.
Read now
Alberto Redaelli, Jennifer M Stephens, Benjamin L Laskin, Chris L Pashos & Marc F Botteman. (2003) The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML. Expert Review of Anticancer Therapy 3:3, pages 311-329.
Read now

Articles from other publishers (19)

Ryan W. Jacobs, Omotayo Fasan, Edward A. Copelan & Belinda R. Avalos. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 1247 1262 .
Belinda R. Avalos & Edward A. Copelan. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 1347 1361 .
Santosh Saraf & Howard Ozer. 2012. Twenty Years of G-CSF. Twenty Years of G-CSF 109 149 .
Andrew Y. Koh & Philip A. Pizzo. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood 1099 1120 .
Julia Bohlius, Christine Herbst, Marcel Reiser, Guido Schwarzer & Andreas Engert. (2008) Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Cochrane Database of Systematic Reviews.
Crossref
Oliver G. Ottmann, Gesine Bug & Jürgen Krauter. (2007) Current Status of Growth Factors in the Treatment of Acute Myeloid and Lymphoblastic Leukemia. Seminars in Hematology 44:3, pages 183-192.
Crossref
S Y Liou, J M Stephens, K T Carpiuc, W Feng, M F Botteman & J W Hay. (2007) Economic Burden of Haematological Adverse Effects in Cancer Patients. Clinical Drug Investigation 27:6, pages 381-396.
Crossref
Thomas J. Smith, James Khatcheressian, Gary H. Lyman, Howard Ozer, James O. Armitage, Lodovico Balducci, Charles L. Bennett, Scott B. Cantor, Jeffrey Crawford, Scott J. Cross, George Demetri, Christopher E. Desch, Philip A. Pizzo, Charles A. Schiffer, Lee Schwartzberg, Mark R. Somerfield, George Somlo, James C. Wade, James L. Wade, Rodger J. Winn, Antoinette J. Wozniak & Antonio C. Wolff. (2006) 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline. Journal of Clinical Oncology 24:19, pages 3187-3205.
Crossref
Jared R. Adams, Cara Angelotta & Charles L. Bennett. (2006) When the Risk of Febrile Neutropenia Is 20%, Prophylactic Colony-Stimulating Factor Use Is Clinically Effective, but Is It Cost-Effective?. Journal of Clinical Oncology 24:19, pages 2975-2977.
Crossref
George D. Demetri. 2006. Oncology. Oncology 1535 1544 .
Jean Delorme, Stéphanie Badin, Anne-Gaelle G. Le Corroller, Anne Aurtignon Auvrignon, Marie-Françoise Auclerc, Virginie Gandemer, Pierre Bordigoni, Jean-Pierre Lamagnere, François Demeocq, Yves Perel, Christian Berthou, François Bauduer, Brigitte Pautard, Jean-Pierre Vannier, Diane Braguer, Thierry Leblanc, Guy Leverger, André Baruchel & Gérard Michel. (2003) Economic Evaluation of Recombinant Human Granulocyte Colony-Stimulating Factor in Very High-Risk Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 25:6, pages 441-447.
Crossref
Charles L Bennett & Glen T Schumock. (2003) Cost Analyses Of Adjunct Colony Stimulating Factors For Older Patients With Acute Myeloid Leukaemia. Drugs & Aging 20:7, pages 479-483.
Crossref
Gary H. Lyman, Nicole M. Kuderer & Lodovico Balducci. (2002) Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patients. Current Opinion in Hematology 9:3, pages 207-214.
Crossref
Lodovico Balducci & Ignazio Carreca. (2002) The Role of Myelopoietic Growth Factors in Managing Cancer in the Elderly. Drugs 62:Supplement 1, pages 47-63.
Crossref
David C. Dale. (2002) Colony-Stimulating Factors for the Management of Neutropenia in Cancer Patients. Drugs 62:Supplement 1, pages 1-15.
Crossref
K Bradstock, J Matthews, G Young, R Lowenthal, H Baxter, C Arthur, J Bashford, T Brighton, P Cannell, L Dunlop, S Durrant, A Enno, P Eliadis, D Gill, A Gillett, D Gottlieb, H Januszewicz, D Joshua, M Leahy, A Schwarer & K Taylor. (2001) Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia. Leukemia 15:9, pages 1331-1338.
Crossref
Lodovico Balducci & Martine Extermann. (2001) A practical approach to the older patient with cancer. Current Problems in Cancer 25:1, pages 7-76.
Crossref
Howard OzerJames O. ArmitageCharles L. BennettJeffrey CrawfordGeorge D. DemetriPhilip A. PizzoCharles A. SchifferThomas J. SmithGeorge SomloJames C. WadeJames L. WadeIIIIIIRodger J. WinnAntoinette J. WozniakMark R. Somerfield. (2000) 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines. Journal of Clinical Oncology 18:20, pages 3558-3585.
Crossref
. (2000) Current Awareness. Hematological Oncology 18:3, pages 121-128.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.